Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | PPARG | P37231 | 1/20 | 0.30 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.30 |
| ▸ | NR2E3 | Q9Y5X4 | 1/20 | 0.30 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.30 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.30 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.30 |
| ▸ | CA12 | O43570 | 1/20 | 0.30 |
| ▸ | CA9 | Q16790 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17405268 | 0.90 | ALDH1A1 (0.31) | HTTALDH1A1PPARGRXFP1NR2E3 | |
| SCHEMBL17405296 | 0.88 | SIRT2 (0.31) | HTTALDH1A1SIRT2SIRT1 | |
| SCHEMBL17405272 | 0.87 | ALDH1A1 (0.32) | HTTALDH1A1PPARGRXFP1NR2E3 | |
| SCHEMBL17405313 | 0.85 | SMN1; SMN2 (0.34) | HTTALDH1A1PPARGRXFP1NR2E3 | |
| SCHEMBL17405336 | 0.79 | KDM4E (0.40) | HTTALDH1A1PPARGRXFP1NR2E3 | |
| SCHEMBL19841359 | 0.79 | ESR1 (0.31) | ALDH1A1 | |
| SCHEMBL18057703 | 0.79 | CA12 (0.38) | HTTALDH1A1PPARGRXFP1NR2E3 | |
| SCHEMBL18057695 | 0.79 | CA12 (0.38) | HTTALDH1A1PPARGRXFP1NR2E3 | |
| SCHEMBL17405301 | 0.79 | MAPT (0.33) | ALDH1A1PPARGRXFP1NR2E3NCOR2 | |
| SCHEMBL17405322 | 0.78 | ALDH1A1 (0.38) | HTTALDH1A1PPARGRXFP1NR2E3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9887367-B2 | Heterocyclic compound, material for organic electroluminescent elements using same, organic electroluminescent element using same, and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2018-02-06 | — | — | US | disclosed |
| US-9887367-B2 | Heterocyclic compound, material for organic electroluminescent elements using same, organic electroluminescent element using same, and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2018-02-06 | — | — | US | disclosed |
| US-20160005977-A1 | HETEROCYCLIC COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS USING SAME, ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2016-01-07 | — | — | US | disclosed |
| US-20160005977-A1 | HETEROCYCLIC COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS USING SAME, ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2016-01-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160005977-A1 | HETEROCYCLIC COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS USING SAME, ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME, AND ELECTRONIC DEVICE | ODC1, NOTUM, OR10J3 | HTT 2182/4885ALDH1A1 1348/4885PPARG 1432/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.